MeSH term
Frequency | Condition_Probility | Female | 10 | 0.0 |
Humans | 21 | 0.0 |
Phenotype | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 18 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Actins/*genetics | 9 | 14.0 |
Aspartic Acid/genetics | 2 | 3.0 |
DNA Mutational Analysis/methods | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Male | 8 | 0.0 |
*Mutation | 4 | 0.0 |
Actins/chemistry/*genetics | 2 | 66.0 |
Adolescent | 5 | 0.0 |
Adult | 6 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 6 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Infant | 5 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Microscopy, Electron | 3 | 0.0 |
Middle Aged | 3 | 0.0 |
Models, Molecular | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Mutation, Missense/*genetics | 2 | 1.0 |
Biopsy | 4 | 0.0 |
Actins/*genetics/metabolism | 2 | 40.0 |
Chromosomes, Human, Pair 1/*genetics | 2 | 0.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Aged | 2 | 0.0 |
Animals | 8 | 0.0 |
Mutation | 3 | 0.0 |
Base Sequence | 3 | 0.0 |
Muscle, Skeletal/*metabolism | 3 | 1.0 |
Myopathies, Nemaline/*genetics | 2 | 18.0 |
Comparative Study | 4 | 0.0 |
DNA Primers | 2 | 0.0 |
Muscle Proteins/metabolism | 2 | 4.0 |
Chromosome Mapping | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Mice | 4 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Actins/genetics | 2 | 1.0 |
Disease Progression | 2 | 0.0 |
